<p>CDKN3 promotes tumor progression and confers cisplatin resistance via RAD51 in esophageal cancer</p>

Jiansong Wang(Weifang Medical University), Zhongmin Jiang(Chinese People's Liberation Army)
Cancer Management and Research
April 1, 2019
Cited by 45


Related Papers